Synthetic ACTH in High Risk Patients with Idiopathic Membranous Nephropathy: A Prospective, Open Label Cohort Study

New therapeutic agents are warranted in idiopathic membranous nephropathy. Synthetic ACTH may be advantageous with reported remission rates up to 85% and few side effects. We conducted a prospective open label cohort study from 2008 till 2010 (NCT00694863). We prospectively selected patients with id...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Logt, Anne-Els, Beerenhout, Charles H., Brink, Hans S., van de Kerkhof, Jos J., Wetzels, Jack F., Hofstra, Julia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642982/
https://www.ncbi.nlm.nih.gov/pubmed/26562836
http://dx.doi.org/10.1371/journal.pone.0142033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642982/
https://www.ncbi.nlm.nih.gov/pubmed/26562836
http://dx.doi.org/10.1371/journal.pone.0142033

Ejemplares similares